囊性纤维化中的类二十烷酸 - Suppr

Suppr

超能文献

Eicosanoids in cystic fibrosis.

作者信息

Kida Yujiro

出版信息

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1. doi: 10.1056/NEJM200405063501916.

DOI:10.1056/NEJM200405063501916

PMID:15128902

Abstract

摘要

相似文献

Eicosanoids in cystic fibrosis.

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1. doi: 10.1056/NEJM200405063501916.

Association of cystic fibrosis with abnormalities in fatty acid metabolism.

N Engl J Med. 2004 Feb 5;350(6):560-9. doi: 10.1056/NEJMoa021218.

Fatty acid metabolism in cystic fibrosis.

Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):121-9. doi: 10.1016/j.plefa.2010.07.002. Epub 2010 Jul 31.

Eicosanoids in cystic fibrosis.

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1.

Fatty acid metabolism in cystic fibrosis.

N Engl J Med. 2004 Feb 5;350(6):605-7. doi: 10.1056/NEJMe038217.

Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.

Prostaglandins Leukot Essent Fatty Acids. 2020 Sep;160:102156. doi: 10.1016/j.plefa.2020.102156. Epub 2020 Jun 26.

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):309-18. doi: 10.1016/j.plefa.2007.10.009. Epub 2007 Nov 26.

Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.

J Pediatr. 2001 Nov;139(5):650-5. doi: 10.1067/mpd.2001.118890.

Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.

J Cyst Fibros. 2006 May;5(2):77-84. doi: 10.1016/j.jcf.2006.01.004. Epub 2006 Feb 28.

Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.

Saudi Med J. 2010 Mar;31(3):339-40; author reply 340.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Eicosanoids in cystic fibrosis.

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1. doi: 10.1056/NEJM200405063501916.

Association of cystic fibrosis with abnormalities in fatty acid metabolism.

N Engl J Med. 2004 Feb 5;350(6):560-9. doi: 10.1056/NEJMoa021218.

Fatty acid metabolism in cystic fibrosis.

Prostaglandins Leukot Essent Fatty Acids. 2010 Sep;83(3):121-9. doi: 10.1016/j.plefa.2010.07.002. Epub 2010 Jul 31.

Eicosanoids in cystic fibrosis.

N Engl J Med. 2004 May 6;350(19):2000-1; author reply 2000-1.

Fatty acid metabolism in cystic fibrosis.

N Engl J Med. 2004 Feb 5;350(6):605-7. doi: 10.1056/NEJMe038217.

Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.

Prostaglandins Leukot Essent Fatty Acids. 2020 Sep;160:102156. doi: 10.1016/j.plefa.2020.102156. Epub 2020 Jun 26.

Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.

Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):309-18. doi: 10.1016/j.plefa.2007.10.009. Epub 2007 Nov 26.

Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.

J Pediatr. 2001 Nov;139(5):650-5. doi: 10.1067/mpd.2001.118890.

Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.

J Cyst Fibros. 2006 May;5(2):77-84. doi: 10.1016/j.jcf.2006.01.004. Epub 2006 Feb 28.

Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.

Saudi Med J. 2010 Mar;31(3):339-40; author reply 340.